Alembic Pharmaceuticals intends to continue building on a strong performance in the US generics sector by lining up more launches and expanding its portfolio beyond its strength in solid oral doses.
In early January, a formulations facility in Karkhadi, India, operated by the firm’s 60/40 Aleor Dermaceuticals skincare joint venture with...







